recombinant human blood coagulation factor viii octocog alfa
UkraineDrugs containing this active substance
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage recombinant human blood coagulation factor viii octocog alfa 250 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage recombinant human blood coagulation factor viii octocog alfa 500 IU ATC: B02BD02
-
The drug is intended for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage recombinant human blood coagulation factor viii octocog alfa 1000 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage recombinant human blood coagulation factor viii octocog alfa 1500 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage recombinant human blood coagulation factor viii octocog alfa 2000 IU ATC: B02BD02
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Form: powder and solvent for injection solution
Active substance Dosage recombinant human blood coagulation factor viii octocog alfa 3000 IU ATC: B02BD02